HBM Partners
Thomas Heimann, MSc has a diverse work experience starting in 2001 with Luzerner Kantonalbank as an Assistant to Customer Relationship Manager until 2005. In 2009, they joined SECA - Swiss Private Equity & Corporate Finance Association as a Researcher until 2011. Thomas then moved to HBM Partners AG in 2009 as an Assistant Private Equity Team until 2011, then as a Controller & Equity Analyst until 2015, and finally shifted to the role of Head Risk Management & Equity Analyst in 2015, which is their current position.
Thomas Heimann obtained a Bachelor of Science (BSc) in Finance & Banking from Lucerne University of Applied Sciences and Arts in 2008. Thomas then went on to pursue a Master of Science (MSc) in Banking & Finance from Lucerne University of Applied Sciences and Arts / Zurich University of Applied Sciences, completing their studies in 2010.
This person is not in any offices
HBM Partners
HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies. HBM Partners has a team of experienced professionals to source, analyse and engage in investments in biopharma, medical devices and diagnostics industries. HBM Partners has a track-record of over 100 investments that resulted so far in significant value creation by more than 60 trade sales and IPOs since inception. HBM Partners is regulated by FINMA and advises SIX listed HBM Healthcare Investments and further specialised public and private equity investment products.